More Than 1,000 Adverse Reactions to COVID Shots Reported in New Brunswick, Canada
According to the Department of Health in New Brunswick, Canada, 1,148 people living in that province suffered an adverse reaction after receiving a COVID-19 shot between Dec. 14, 2020 and Jan. 14, 2023. It was reported that 313 of the reactions were considered “serious.”1
Health Canada, the department of the Canadian government responsible for national health policy, has approved six COVID biologics for use in Canada, including Moderna/NIAID’s Spikevax, Pfizer/BioNTech’s Comirnaty, Johnson & Johnson/Janssen’s JNJ-78436735, Novavax’s Nuvaxovid, AstraZeneca/Oxford University’s Vaxzevria and Medicago’s Covifenz.2
Adam Bowie, the spokesperson for the New Brunswick Department of Health did not provide specific information on the type of adverse reactions or the demographics of the patients who reported the reactions. However, the Public Health Agency of Canada responsible for public health, emergency preparedness and response defines a serious adverse reaction if it is fatal; life-threatening, such as an anaphylactic episode; a severe allergic reaction; requires in-patient hospitalization or prolongation of existing hospitalization; results in persistent or significant disability, and/or results in a congenital birth defects.3
CDC Dismisses Potential Link Between Ischemic Strokes and the Pfizer/BioNTech COVID Bivalent Booster Shot
In January 2023, the U.S. Centers for Disease Control and Prevention (CDC) detected a safety concern for ischemic stroke in people ages 65 and older who received the Comirnaty bivalent booster shot, but concluded that the data suggests it is unlikely that the signal in CDC’s Vaccine Safety Datalink (VSD) monitoring system represents a real clinical risk. Based on this conclusion, the CDC’s recommendation for COVID vaccination remained unchanged.4
Adam Bowie from the New Brunswick Department of Health said:
So far, these safety concerns have not been raised through other vaccine safety monitoring systems in the United States, or in other countries—including Canada. It should be noted the CDC did not recommend any changes to vaccination practices at this time, and that these adverse events have not yet been confirmed to have been caused by the vaccines administered. Additional analysis and reviews must be completed to further explore the causes of these reactions and that data is used as part of the continuous monitoring of the safety of these vaccines.5
Despite a significant number of serious adverse reactions, the New Brunswick Department of Health’s recommendations for COVID vaccination remains unchanged.6
If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.
Click here to view References:
No comments:
Post a Comment